Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 118.69% is 372% above its 5-year average of -43.59%, near the high end of its 5-year range (-149.33%–118.69%).
472.54% above its 12-month average of -31.86%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -17.52%.
RETURN ON ASSETS (ROA)
118.69%
RETURN ON ASSETS (ROA) AVG TTM
-31.86%
RETURN ON ASSETS (ROA) AVG 3Y
-49.56%
RETURN ON ASSETS (ROA) AVG 5Y
-43.59%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+472.54%
CURRENT VS 3Y AVG
+339.51%
CURRENT VS 5Y AVG
+372.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+468.15%
vs the sector median at left
Elutia Inc
Market Cap
$34.35M
Return on Assets (ROA)
118.69%
TTM Avg
-31.86%
3Y Avg
-49.56%
5Y Avg
-43.59%
Market Cap
$34.97M
Return on Assets (ROA)
-136.91%
TTM Avg
-90.70%
3Y Avg
-79.79%
5Y Avg
-214.88%
Market Cap
$33.63M
Return on Assets (ROA)
-176.33%
TTM Avg
-88.31%
3Y Avg
-79.12%
5Y Avg
-81.37%
Market Cap
$33.61M
Return on Assets (ROA)
-42.84%
TTM Avg
-15.31%
3Y Avg
-31.73%
5Y Avg
-29.34%
Market Cap
$33.29M
Return on Assets (ROA)
-114.53%
TTM Avg
-107.26%
3Y Avg
-84.46%
5Y Avg
-72.21%
Market Cap
$35.52M
Return on Assets (ROA)
-60.08%
TTM Avg
-119.59%
3Y Avg
-67.97%
5Y Avg
-67.17%
Market Cap
$35.76M
Return on Assets (ROA)
-103.00%
TTM Avg
-39.81%
3Y Avg
-17.36%
5Y Avg
-12.69%
Market Cap
$32.93M
Return on Assets (ROA)
-39.14%
TTM Avg
-11.59%
3Y Avg
6.23%
5Y Avg
18.56%
Market Cap
$35.84M
Return on Assets (ROA)
-110.85%
TTM Avg
-107.44%
3Y Avg
-115.17%
5Y Avg
-101.88%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $34.35M | 118.69% | -31.86% | -49.56% | -43.59% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | -136.91% | -90.70% | -79.79% | -214.88% |
| Scilex Holding Company (SCLX)vs › | $33.63M | -176.33% | -88.31% | -79.12% | -81.37% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.61M | -42.84% | -15.31% | -31.73% | -29.34% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.29M | -114.53% | -107.26% | -84.46% | -72.21% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | -60.08% | -119.59% | -67.97% | -67.17% |
| DocGo Inc. (DCGO)vs › | $35.76M | -103.00% | -39.81% | -17.36% | -12.69% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $32.93M | -39.14% | -11.59% | 6.23% | 18.56% |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | -110.85% | -107.44% | -115.17% | -101.88% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | -120.78% | -168.59% | -147.82% | -131.31% |
ROA
118.7%
ROE
329.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 85.61% |
| 2024-12-31 | -149.33% |
| 2023-12-31 | -86.71% |
| 2022-12-31 | -47.79% |
| 2021-12-31 | -36.97% |
| 2020-12-31 | -26.36% |
| 2019-12-31 | -26.67% |
| 2018-12-31 | -24.23% |
